| Application no. and date | 00920889.3 (espacenet) (Federated) (European Patent Register), 20000419 | | Patent/reg. no. and date | DK/EP 1173434, 20030820 | | Publication date | 20020123 | | Priority no. and date | GB 9909472, 19990423, GB 9912197, 19990525 | | EP pub. no. and date |
EP 1173434 20020123 | | Effective date | | | Applicant/owner | SmithKline Beecham plc, 980 Great West Road
Brentford,
Middlesex TW8 9GS, GB | | Applicant ref. no. | P200301784 | | Inventor | BLACKLER, Paul D. J.,
SmithKline Beecham Pharm., Old Powder Mills
Near Leigh
Tonbridge,
Kent TN11 9AN, GB,
GILES, Robert Gordon,
SmithKline Beecham Pharm., Old Powder Mills
Near Leigh
Tonbridge
Kent TN11 9AN, GB,
SASSE, Michael John
SmithKline Beecham Pharm., Old Powder Mills
Near Leigh
Tonbridge
Kent TN11 9AN, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/427 (2006.01) , A61P 3/10 (2006.01) , C07D 417/12 (2006.01) | | Title | Thiazolidindionderivat og dets anvendelse som antidiabetisk middel | | Int. application no. | GB2000001514 | | Int. publication no. | WO2000064892 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
